Bellevue Group AG - Q4 2017 holdings

$957 Million is the total value of Bellevue Group AG's 134 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 11.5% .

 Value Shares↓ Weighting
CELG BuyCELGENE CORP$42,191,000
-12.9%
404,265
+21.6%
4.41%
-13.0%
ANTM BuyANTHEM INC$40,788,000
+25.5%
181,243
+5.9%
4.26%
+25.4%
ALGN SellALIGN TECHNOLOGY INC$38,578,000
+7.5%
173,596
-9.9%
4.03%
+7.4%
ISRG BuyINTUITIVE SURGICAL INC$35,083,000
+10.5%
96,131
+216.5%
3.66%
+10.3%
ILMN SellILLUMINA INC$32,748,000
+0.5%
149,873
-8.3%
3.42%
+0.4%
UNH BuyUNITEDHEALTH GROUP INC$31,506,000
+18.1%
142,910
+4.9%
3.29%
+17.9%
ABT BuyABBOTT LABS$30,247,000
+12.7%
530,000
+5.4%
3.16%
+12.6%
INCY BuyINCYTE CORP$21,933,000
+28.4%
231,576
+58.2%
2.29%
+28.2%
WBA BuyWALGREENS BOOTS ALLIANCE INC$21,536,000
+6.5%
296,560
+13.2%
2.25%
+6.4%
EW SellEDWARDS LIFESCIENCES CORP$21,212,000
-5.7%
188,200
-8.6%
2.22%
-5.9%
JAZZ BuyJAZZ PHARMACEUTICALS PLC$20,943,000
+24.2%
155,582
+35.0%
2.19%
+24.1%
HOLX BuyHOLOGIC INC$20,686,000
+55.3%
483,894
+33.3%
2.16%
+55.1%
LLY  LILLY ELI & CO$20,388,000
-1.2%
241,2620.0%2.13%
-1.3%
ABC BuyAMERISOURCEBERGEN CORP$19,369,000
+18.2%
210,941
+6.5%
2.02%
+18.0%
DHR BuyDANAHER CORP DEL$18,750,000
+37.6%
202,000
+27.2%
1.96%
+37.5%
MDT  MEDTRONIC PLC$17,523,000
+3.8%
217,0000.0%1.83%
+3.7%
BSX  BOSTON SCIENTIFIC CORP$17,254,000
-15.0%
696,0000.0%1.80%
-15.1%
BIIB SellBIOGEN INC$16,661,000
-9.7%
52,300
-11.2%
1.74%
-9.7%
ALXN BuyALEXION PHARMACEUTICALS INC$15,639,000
+29.6%
130,770
+52.1%
1.63%
+29.5%
DXCM BuyDEXCOM INC$15,306,000
+595.1%
266,740
+492.8%
1.60%
+595.2%
VRTX BuyVERTEX PHARMACEUTICALS INC$14,418,000
+58.6%
96,210
+60.9%
1.51%
+58.4%
HRC  HILL ROM HLDGS INC$14,324,000
+13.9%
169,9390.0%1.50%
+13.8%
AMGN SellAMGEN INC$14,216,000
-61.6%
81,750
-58.8%
1.48%
-61.6%
SYK BuySTRYKER CORP$14,137,000
+18.1%
91,300
+8.3%
1.48%
+18.0%
BAX  BAXTER INTL INC$13,962,000
+3.0%
216,0000.0%1.46%
+2.9%
GILD SellGILEAD SCIENCES INC$12,974,000
-60.2%
181,100
-55.0%
1.36%
-60.3%
IONS SellIONIS PHARMACEUTICALS INC$12,908,000
-4.2%
256,706
-3.4%
1.35%
-4.3%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored adr$12,733,000
+24.4%
671,940
+15.5%
1.33%
+24.2%
WMGI  WRIGHT MED GROUP NV$12,028,000
-14.2%
541,8010.0%1.26%
-14.3%
LIVN SellLIVANOVA PLC$11,770,000
+6.3%
147,269
-6.8%
1.23%
+6.2%
BDX  BECTON DICKINSON & CO$11,773,000
+9.2%
55,0000.0%1.23%
+9.1%
CI BuyCIGNA CORPORATION$11,708,000
+31.4%
57,650
+21.0%
1.22%
+31.2%
CNC SellCENTENE CORP DEL$11,641,000
+1.1%
115,390
-3.0%
1.22%
+1.0%
HZNP BuyHORIZON PHARMA PLC$11,593,000
+87.8%
794,062
+63.2%
1.21%
+87.5%
MGNX BuyMACROGENICS INC$10,724,000
+33.9%
564,401
+30.3%
1.12%
+33.8%
REGN SellREGENERON PHARMACEUTICALS$10,452,000
-22.6%
27,800
-7.9%
1.09%
-22.7%
BGNE NewBEIGENE LTDsponsored adr$10,129,000103,650
+100.0%
1.06%
ZBH SellZIMMER BIOMET HLDGS INC$10,016,000
-8.0%
83,000
-10.8%
1.05%
-8.2%
MYL BuyMYLAN N V$9,998,000
+75.9%
236,300
+30.4%
1.04%
+75.8%
SUPN NewSUPERNUS PHARMACEUTICALS INC$9,580,000240,400
+100.0%
1.00%
THC  TENET HEALTHCARE CORP$9,344,000
-7.7%
616,7960.0%0.98%
-7.8%
LH BuyLABORATORY CORP AMER HLDGS$9,063,000
+9.8%
56,820
+3.9%
0.95%
+9.7%
SHPG BuySHIRE PLCsponsored adr$8,754,000
+34.7%
56,435
+33.0%
0.92%
+34.6%
IART BuyINTEGRA LIFESCIENCES HLDGS C$8,720,000
-2.3%
182,200
+3.0%
0.91%
-2.5%
HUM BuyHUMANA INC$8,273,000
+8.3%
33,350
+6.4%
0.86%
+8.1%
TSRO BuyTESARO INC$5,975,000
+320.8%
72,100
+555.5%
0.62%
+318.8%
HCM BuyHUTCHISON CHINA MEDTECH LTDsponsored adr$5,258,000
+200.3%
133,850
+107.3%
0.55%
+200.0%
ABMD SellABIOMED INC$5,060,000
-64.7%
27,000
-68.3%
0.53%
-64.8%
TMO  THERMO FISHER SCIENTIFIC INC$4,900,000
+0.3%
25,8080.0%0.51%
+0.2%
COO SellCOOPER COS INC$4,855,000
-14.7%
22,300
-7.1%
0.51%
-14.8%
NKTR SellNEKTAR THERAPEUTICS$4,461,000
+51.1%
74,700
-39.3%
0.47%
+50.8%
NBIX SellNEUROCRINE BIOSCIENCES INC$4,229,000
+23.2%
54,500
-2.7%
0.44%
+23.1%
BMRN SellBIOMARIN PHARMACEUTICAL INC$4,017,000
-11.6%
45,050
-7.7%
0.42%
-11.6%
RMD  RESMED INC$3,980,000
+10.0%
47,0000.0%0.42%
+10.1%
AET SellAETNA INC NEW$3,969,000
-56.0%
22,000
-61.2%
0.42%
-56.0%
ESRX  EXPRESS SCRIPTS HLDG CO$3,695,000
+17.9%
49,5000.0%0.39%
+17.7%
JNJ SellJOHNSON & JOHNSON$3,633,000
-11.3%
26,000
-17.5%
0.38%
-11.2%
XRAY  DENTSPLY SIRONA INC$3,588,000
+10.1%
54,5000.0%0.38%
+10.0%
TFX BuyTELEFLEX INC$3,483,000
+41.1%
14,000
+37.3%
0.36%
+41.1%
LGND SellLIGAND PHARMCEUTICALS INC$3,478,000
-47.5%
25,400
-47.8%
0.36%
-47.7%
BLUE SellBLUEBIRD BIO INC$3,402,000
-1.3%
19,100
-23.9%
0.36%
-1.7%
MOH  MOLINA HEALTHCARE INC$3,336,000
+11.5%
43,5000.0%0.35%
+11.5%
GNMK BuyGENMARK DIAGNOSTICS INC$3,226,000
-36.0%
773,677
+47.7%
0.34%
-36.1%
HSIC BuySCHEIN HENRY INC$3,005,000
-3.6%
43,000
+13.2%
0.31%
-3.7%
LABU NewDIREXION SHS ETF TRsp biotch bl new$2,989,00038,400
+100.0%
0.31%
CERN SellCERNER CORP$2,965,000
-44.2%
44,000
-40.9%
0.31%
-44.2%
PRGO SellPERRIGO CO PLC$2,878,000
-26.8%
33,000
-29.0%
0.30%
-26.8%
SGEN BuySEATTLE GENETICS INC$2,862,000
+16.9%
53,500
+18.9%
0.30%
+16.8%
ALKS SellALKERMES PLC$2,830,000
-0.8%
51,700
-7.8%
0.30%
-0.7%
ALNY SellALNYLAM PHARMACEUTICALS INC$2,808,000
-68.4%
22,100
-70.8%
0.29%
-68.5%
AGN SellALLERGAN PLC$2,699,000
-35.8%
16,500
-19.5%
0.28%
-35.8%
UTHR SellUNITED THERAPEUTICS CORP DEL$2,545,000
+0.6%
17,200
-20.4%
0.27%
+0.4%
AGIO SellAGIOS PHARMACEUTICALS INC$2,338,000
-22.2%
40,900
-9.1%
0.24%
-22.3%
MCK SellMCKESSON CORP$2,152,000
-22.2%
13,800
-23.3%
0.22%
-22.1%
PTLA BuyPORTOLA PHARMACEUTICALS INC$2,110,000
+24.0%
43,350
+37.6%
0.22%
+23.6%
SAGE NewSAGE THERAPEUTICS INC$2,084,00012,650
+100.0%
0.22%
GMED SellGLOBUS MED INCcl a$2,008,000
+22.8%
48,850
-11.2%
0.21%
+22.8%
HCSG  HEALTHCARE SVCS GRP INC$2,003,000
-2.3%
38,0000.0%0.21%
-2.8%
JUNO SellJUNO THERAPEUTICS INC$1,915,000
-0.7%
41,900
-2.6%
0.20%
-1.0%
RARE SellULTRAGENYX PHARMACEUTICAL INC$1,897,000
-15.2%
40,900
-2.6%
0.20%
-15.4%
NUVA SellNUVASIVE INC$1,890,000
-26.2%
32,312
-30.1%
0.20%
-26.5%
ABBV SellABBVIE INC$1,886,000
-79.3%
19,500
-81.0%
0.20%
-79.4%
IRTC  IRHYTHM TECHNOLOGIES INC$1,872,000
+8.0%
33,4000.0%0.20%
+8.3%
HCA  HCA HEALTHCARE INC$1,871,000
+10.4%
21,3000.0%0.20%
+10.2%
QTRX NewQUANTERIX CORP$1,799,00083,800
+100.0%
0.19%
EGRX SellEAGLE PHARMACEUTICALS INC$1,763,000
-63.8%
33,000
-59.5%
0.18%
-63.9%
QGEN SellQIAGEN NV$1,751,000
-9.8%
56,611
-8.1%
0.18%
-9.9%
ANGO  ANGIODYNAMICS INC$1,691,000
-2.7%
101,7000.0%0.18%
-2.7%
TDOC  TELADOC INC$1,638,000
+5.1%
47,0000.0%0.17%
+4.9%
TRHC BuyTABULA RASA HEALTHCARE INC$1,627,000
+9.8%
58,000
+4.7%
0.17%
+9.7%
PEN  PENUMBRA INC$1,581,000
+4.2%
16,8000.0%0.16%
+3.8%
HALO SellHALOZYME THERAPEUTICS INC$1,560,000
+2.5%
77,000
-12.1%
0.16%
+2.5%
MRK  MERCK & CO INC$1,547,000
-12.2%
27,5000.0%0.16%
-12.0%
EXEL SellEXELIXIS INC$1,538,000
+22.1%
50,600
-2.7%
0.16%
+22.0%
IBB BuyISHARES TRnasdaq biotech$1,441,000
-52.0%
13,500
+50.0%
0.15%
-51.9%
MASI  MASIMO CORP$1,442,000
-2.0%
17,0000.0%0.15%
-1.9%
ITCI BuyINTRA CELLULAR THERAPIES INC$1,339,000
+112.2%
92,500
+131.2%
0.14%
+112.1%
CHRS NewCOHERUS BIOSCIENCES INC$1,320,000150,000
+100.0%
0.14%
EARS  AURIS MED HLDG AG$1,281,000
-28.0%
2,169,6250.0%0.13%
-28.0%
PODD  INSULET CORP$1,242,000
+25.3%
18,0000.0%0.13%
+25.0%
XENT SellINTERSECT ENT INC$1,245,000
-2.5%
38,430
-6.3%
0.13%
-3.0%
IPXL SellIMPAX LABORATORIES INC$1,249,000
-29.3%
75,000
-13.8%
0.13%
-29.7%
CLVS SellCLOVIS ONCOLOGY INC$1,224,000
-19.7%
18,000
-2.7%
0.13%
-19.5%
CAH  CARDINAL HEALTH INC$1,225,000
-8.4%
20,0000.0%0.13%
-8.6%
PRTA SellPROTHENA CORP PLC$1,175,000
-51.5%
31,350
-16.2%
0.12%
-51.4%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$1,133,000
+129.8%
19,400
+128.2%
0.12%
+126.9%
RDUS SellRADIUS HEALTH INC$1,074,000
-23.7%
33,800
-7.4%
0.11%
-23.8%
PFE  PFIZER INC$1,058,000
+1.5%
29,2000.0%0.11%
+1.8%
ACAD SellACADIA PHARMACEUTICALS INC$1,055,000
-76.1%
35,050
-70.0%
0.11%
-76.1%
DVAX SellDYNAVAX TECHNOLOGIES CORP$1,029,000
-19.5%
55,000
-7.6%
0.11%
-20.1%
OMCL NewOMNICELL INC$970,00020,000
+100.0%
0.10%
HMSY  HMS HLDGS CORP$907,000
-14.7%
53,5000.0%0.10%
-14.4%
VAR  VARIAN MED SYS INC$778,000
+11.1%
7,0000.0%0.08%
+11.0%
GKOS  GLAUKOS CORP$770,000
-22.2%
30,0000.0%0.08%
-23.1%
NVRO  NEVRO CORP$739,000
-24.0%
10,7000.0%0.08%
-24.5%
CLLS NewCELLECTIS S Asponsored ads$710,00024,350
+100.0%
0.07%
COTV  COTIVITI HLDGS INC$699,000
-10.5%
21,7080.0%0.07%
-11.0%
GWPH SellGW PHARMACEUTICALS PLCads$653,000
+7.2%
4,950
-17.5%
0.07%
+6.2%
CVS  CVS HEALTH CORP$638,000
-10.9%
8,8000.0%0.07%
-10.7%
INO SellINOVIO PHARMACEUTICALS INC$579,000
-36.6%
140,100
-2.7%
0.06%
-36.8%
BIVV SellBIOVERATIV INC$550,000
-57.6%
10,200
-55.2%
0.06%
-58.1%
QTNT  QUOTIENT LTD$545,000
+0.6%
110,0000.0%0.06%0.0%
ESPR SellESPERION THERAPEUTICS INC NEW$514,000
+28.2%
7,800
-2.5%
0.05%
+28.6%
MLNT NewMELINTA THERAPEUTICS INC$507,00032,100
+100.0%
0.05%
MDCO SellMEDICINES CO$488,000
-32.4%
17,850
-8.5%
0.05%
-32.9%
ENDP SellENDO INTL PLC$490,000
-50.3%
63,200
-45.0%
0.05%
-50.5%
EVHC  ENVISION HEALTHCARE CORP$450,000
-23.2%
13,0260.0%0.05%
-23.0%
MYGN SellMYRIAD GENETICS INC$412,000
-12.3%
12,000
-7.7%
0.04%
-12.2%
AACH  AAC HLDGS INC$405,000
-9.4%
45,0000.0%0.04%
-10.6%
SGRY  SURGERY PARTNERS INC$375,000
+16.8%
31,0000.0%0.04%
+14.7%
ALDR SellALDER BIOPHARMACEUTICALS INC$350,000
-13.4%
30,600
-7.3%
0.04%
-11.9%
ACHC SellACADIA HEALTHCARE COMPANY IN$326,000
-78.0%
10,000
-67.7%
0.03%
-78.1%
OBLN  OBALON THERAPEUTICS INC$317,000
-30.6%
48,0000.0%0.03%
-31.2%
TBPH SellTHERAVANCE BIOPHARMA INC$296,000
-40.1%
10,628
-26.3%
0.03%
-40.4%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-160,000
-100.0%
-0.05%
ADMS ExitADAMAS PHARMACEUTICALS INC$0-24,000
-100.0%
-0.05%
CEMP ExitCEMPRA INC$0-165,000
-100.0%
-0.06%
Q ExitQUINTILES IMS HOLDING INC$0-71,170
-100.0%
-0.71%
BCR ExitBARD C R INC$0-22,740
-100.0%
-0.76%
MNKKQ ExitMALLINCKRODT PUB LTD CO$0-229,983
-100.0%
-0.90%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Bellevue Asset Management AG #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IONIS PHARMACEUTICALS INC31Q3 20239.3%
Vertex Pharmaceuticals Incorporated31Q3 20235.9%
NEUROCRINE BIOSCIENCES INC31Q3 20235.7%
Incyte Corporation31Q3 20235.4%
INTUITIVE SURGICAL INC31Q3 20234.7%
ABBOTT LABS31Q3 20234.6%
ELEVANCE HEALTH INC31Q3 20234.3%
UnitedHealth Group Incorporated31Q3 20233.6%
ALNYLAM PHARMACEUTICALS INC31Q3 20233.7%
Boston Scientific Corporation31Q3 20232.5%

View Bellevue Group AG's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G2023-02-14
SC 13G2023-02-14
13F-HR2022-11-14

View Bellevue Group AG's complete filings history.

Compare quarters

Export Bellevue Group AG's holdings